Role of FoxO Proteins in Cellular Response to Antitumor Agents

Giovanni Luca Beretta1, Cristina Corno2, Nadia Zaffaroni3

  • 1Molecular Pharmacology Unit, Department of Applied Research and Technological Development, Fondazione IRCCS Istituto Nazionale dei Tumori, 20133 Milan, Italy. giovanni.beretta@istitutotumori.mi.it.

Cancers
|January 17, 2019
PubMed

Insights

Forkhead box proteins (FoxOs) influence cancer cell responses to antitumor drugs. Modulating FoxO levels and localization can enhance sensitivity to treatments like cisplatin and gefitinib, impacting drug resistance.

Area of Science:

  • Molecular Biology
  • Cancer Research
  • Pharmacology

Background:

  • Forkhead box proteins (FoxOs) are transcription factors regulating cell cycle, apoptosis, and drug resistance.
  • FoxOs' activity is modulated by post-translational modifications and microRNA networks.
  • Altered FoxO expression is linked to tumor cell resistance to various anticancer agents.

Purpose of the Study:

  • To review the role of FoxO transcription factors in tumor cell response to drug treatment.
  • To discuss the impact of FoxO expression on drug sensitivity and resistance.
  • To explore therapeutic strategies targeting FoxO localization for improved cancer treatment.

Main Methods:

  • Literature review of studies investigating FoxO proteins in cancer drug response.
  • Analysis of the impact of post-translational modifications and microRNAs on FoxO activity.
  • Examination of specific FoxO family members (FoxO1, FoxO3) in relation to drug sensitivity.

Main Results:

  • Reduced FoxO1 expression correlates with resistance to cisplatin and reduced efficacy of drug combinations in ovarian cancer.
  • FoxO3 mediates cisplatin toxicity in colorectal cancer and is required for gefitinib-induced apoptosis.
  • Nuclear retention of FoxO1 enhances sensitivity to cisplatin by promoting pro-apoptotic gene expression.

Conclusions:

  • FoxO proteins play a critical role in modulating tumor cell sensitivity and resistance to anticancer drugs.
  • Targeting FoxO1 localization presents a promising strategy to overcome drug resistance.
  • Understanding FoxO function is crucial for developing novel therapeutic approaches in oncology.

Related Concept Videos

Inflammatory Response I: Vascular and Cellular01:30

Inflammatory Response I: Vascular and Cellular

The inflammatory response is the body's defense against infection, injury, or irritation from bacteria, trauma, toxins, or heat. Inflammation helps locate and destroy pathogens and remove damaged tissue elements to heal the body. During this initial phase, fluid, blood products, and nutrients migrate to the injured area, resulting in redness, heat, swelling, ache, and loss of function. Moreover, signs of systemic inflammation include fever, increased WBC count, malaise, anorexia, nausea,...
16.4K
Role of Proteins in the Human Body01:28

Role of Proteins in the Human Body

Proteins are the building block of life. They are also  the most abundant macromolecules with as many diverse roles in the body. They are part of many structural components that provide unique shapes and structures to animal cells, tissues, and organs. In addition, they also act as biological catalysts and carry out several anabolic and catabolic reactions. Notably, some proteins are chemical messengers and regulate many critical processes, such as metabolism, growth, and development. They...
6.4K
The Unfolded Protein Response01:37

The Unfolded Protein Response

The ER is the hub of protein synthesis in a cell. It has robust systems to quality control protein folding and also for degradation of terminally misfolded proteins. Under normal conditions, a small proportion of misfolded proteins that cannot be salvaged need to be transported to the cytoplasm by the ER-associated degradation or ERAD pathways. However, if the ERAD cannot handle the misfolded proteins, the cell activates the unfolded protein response or UPR to adjust the protein folding...
6.4K
Regulation of the Unfolded Protein Response01:31

Regulation of the Unfolded Protein Response

Inositol-requiring kinase one or IRE1 is the most conserved eukaryotic unfolded protein response (UPR) receptor. It is a type I transmembrane protein kinase receptor with a distinctive site-specific RNase activity. As the binding mechanics of the misfolded proteins with the N-terminal domain of IRE-1 are unclear, three binding models — direct, indirect, and allosteric -- are proposed for receptor activation. Nevertheless, it is known that once a misfolded protein associates with IRE1, it...
3.0K
Regulated Protein Degradation02:58

Regulated Protein Degradation

It is vital to regulate the activity of enzymatic as well as non-enzymatic proteins inside the cell. This can be achieved either through creating a balance between their rate of synthesis and degradation or regulating the intrinsic activity of the protein. Both these regulation mechanisms play an essential role in the normal functioning of cells.
Protein degradation plays two important roles in the cells. It helps to protect cells from misfolded or damaged proteins before they lead to a...
8.8K
Subviral Agents01:29

Subviral Agents

Subviral agents are infectious entities that resemble viruses but lack one or more viral components, such as a capsid or essential replication machinery. These agents include viroids, prions, and satellites, each possessing distinct structural and functional characteristics that influence their mode of infection and replication.Viroids are the simplest subviral agents, consisting of circular, single-stranded RNA molecules without a protein coat. They exclusively infect plants, relying entirely...
559